BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10585318)

  • 1. High serum hyaluronan indicates poor survival in renal replacement therapy.
    Stenvinkel P; Heimbürger O; Wang T; Lindholm B; Bergström J; Elinder CG
    Am J Kidney Dis; 1999 Dec; 34(6):1083-8. PubMed ID: 10585318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
    Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
    Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
    Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hyaluronan concentrations predict survival in patients with chronic renal failure on maintenance haemodialysis.
    Woodrow G; Turney JH; Davison AM; Cooper EH
    Nephrol Dial Transplant; 1996 Jan; 11(1):98-100. PubMed ID: 8649660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
    Akgul A; Bilgic A; Sezer S; Arat Z; Ozdemir FN; Haberal M
    J Ren Nutr; 2008 Jul; 18(4):338-46. PubMed ID: 18558298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
    J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nutritional status, comorbidity, and inflammation in hemodialysis].
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Vázquez A
    Nefrologia; 2000; 20(6):540-9. PubMed ID: 11217649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and malnutrition as predictors of mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Díez JJ; Vázquez A
    J Nephrol; 2002; 15(2):136-43. PubMed ID: 12018629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
    Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
    Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary dysfunction is possibly a marker of malnutrition and inflammation but not mortality in patients with end-stage renal disease.
    Yoon SH; Choi NW; Yun SR
    Nephron Clin Pract; 2009; 111(1):c1-6. PubMed ID: 19023220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients.
    Terrier N; Senécal L; Dupuy AM; Jaussent I; Delcourt C; Leray H; Rafaelsen S; Bosc JY; Maurice F; Canaud B; Cristol JP
    Hemodial Int; 2005 Apr; 9(2):159-68. PubMed ID: 16191065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictors of early death during dialysis].
    Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
    Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
    Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
    J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study.
    Nascimento MM; Pecoits-Filho R; Qureshi AR; Hayashi SY; Manfro RC; Pachaly MA; Renner L; Stenvinkel P; Lindholm B; Riella MC
    Nephrol Dial Transplant; 2004 Nov; 19(11):2803-9. PubMed ID: 15496560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.